ID24306A - KUINOLIN-2 CARCOXICATE ACID DECREASE AND ITS USE AS AMITO EXITATORY AMINO ANTAGONISTS - Google Patents
KUINOLIN-2 CARCOXICATE ACID DECREASE AND ITS USE AS AMITO EXITATORY AMINO ANTAGONISTSInfo
- Publication number
- ID24306A ID24306A IDW991108A ID991108A ID24306A ID 24306 A ID24306 A ID 24306A ID W991108 A IDW991108 A ID W991108A ID 991108 A ID991108 A ID 991108A ID 24306 A ID24306 A ID 24306A
- Authority
- ID
- Indonesia
- Prior art keywords
- kuinolin
- carcoxicate
- amito
- antagonists
- acid decrease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9706294.7A GB9706294D0 (en) | 1997-03-26 | 1997-03-26 | Heterocyclic compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID24306A true ID24306A (en) | 2000-07-13 |
Family
ID=10809909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW991108A ID24306A (en) | 1997-03-26 | 1998-03-24 | KUINOLIN-2 CARCOXICATE ACID DECREASE AND ITS USE AS AMITO EXITATORY AMINO ANTAGONISTS |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0971896A1 (en) |
| JP (1) | JP2001518901A (en) |
| KR (1) | KR20010005567A (en) |
| CN (1) | CN1257482A (en) |
| AP (1) | AP9901659A0 (en) |
| AU (1) | AU731394B2 (en) |
| BR (1) | BR9808424A (en) |
| CA (1) | CA2284710A1 (en) |
| EA (1) | EA199900755A1 (en) |
| GB (1) | GB9706294D0 (en) |
| HU (1) | HUP0001661A3 (en) |
| ID (1) | ID24306A (en) |
| IL (1) | IL131919A0 (en) |
| IS (1) | IS5186A (en) |
| NO (1) | NO994679L (en) |
| NZ (1) | NZ337793A (en) |
| PL (1) | PL335865A1 (en) |
| TR (1) | TR199902315T2 (en) |
| WO (1) | WO1998042673A1 (en) |
| YU (1) | YU47699A (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9917822D0 (en) * | 1999-07-29 | 1999-09-29 | Imperial College | Nmda antagonist |
| DE10132725A1 (en) | 2001-07-05 | 2006-08-03 | Grünenthal GmbH | Substituted γ-lactone compounds |
| DE10137487A1 (en) | 2001-08-03 | 2003-03-27 | Gruenenthal Gmbh | Substituted 5,6,6a, 11b-tetrahydro-7-oxa-6-aza-benzo [c] fluorene-6-carboxylic acid derivatives |
| DE10306202A1 (en) | 2003-02-13 | 2004-08-26 | Grünenthal GmbH | 2-(hetero)aryl-2-(N-((hetero)aryl)-amino)-acetic acid derivatives useful e.g. for treating anxiety, inflammation, allergy, depression, diarrhea or especially pain is NMDA antagonist |
| JP4360891B2 (en) | 2003-12-09 | 2009-11-11 | アルパイン株式会社 | Electronic device having broadcast receiving function and display method of electronic program guide in the device |
| RU2451014C2 (en) * | 2005-07-22 | 2012-05-20 | Мотида Фармасьютикал Ко., Лтд. | Novel heterocyclidene acetamide derivative |
| KR101136183B1 (en) * | 2005-07-22 | 2012-04-17 | 모찌다 세이야쿠 가부시끼가이샤 | Novel heterocyclidene acetamide derivative |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| AU2018284335A1 (en) | 2017-06-12 | 2020-01-30 | Glytech Llc. | Treatment of depression with NMDA antagonists and D2/5HT2A or selective 5HT2A antagonists |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL93610A0 (en) * | 1989-03-08 | 1990-12-23 | Merck Sharp & Dohme | Tetrahydroquinoline derivatives,their preparation and pharmaceutical compositions containing them |
| CA2232509A1 (en) * | 1995-09-29 | 1997-04-10 | Glaxo Wellcome Spa | Tetrahydroquinolines as nmda antagonists |
| GB9617305D0 (en) * | 1996-08-17 | 1996-09-25 | Glaxo Wellcome Spa | Heterocyclic compounds |
-
1997
- 1997-03-26 GB GBGB9706294.7A patent/GB9706294D0/en active Pending
-
1998
- 1998-03-24 CN CN98805302A patent/CN1257482A/en active Pending
- 1998-03-24 JP JP54323498A patent/JP2001518901A/en active Pending
- 1998-03-24 EP EP98919133A patent/EP0971896A1/en not_active Withdrawn
- 1998-03-24 EA EA199900755A patent/EA199900755A1/en unknown
- 1998-03-24 AU AU72094/98A patent/AU731394B2/en not_active Ceased
- 1998-03-24 KR KR1019997008630A patent/KR20010005567A/en not_active Application Discontinuation
- 1998-03-24 NZ NZ337793A patent/NZ337793A/en unknown
- 1998-03-24 IL IL13191998A patent/IL131919A0/en unknown
- 1998-03-24 TR TR1999/02315T patent/TR199902315T2/en unknown
- 1998-03-24 BR BR9808424-0A patent/BR9808424A/en not_active IP Right Cessation
- 1998-03-24 HU HU0001661A patent/HUP0001661A3/en unknown
- 1998-03-24 CA CA002284710A patent/CA2284710A1/en not_active Abandoned
- 1998-03-24 AP APAP/P/1999/001659A patent/AP9901659A0/en unknown
- 1998-03-24 WO PCT/EP1998/001700 patent/WO1998042673A1/en not_active Application Discontinuation
- 1998-03-24 YU YU47699A patent/YU47699A/en unknown
- 1998-03-24 ID IDW991108A patent/ID24306A/en unknown
- 1998-03-24 PL PL98335865A patent/PL335865A1/en unknown
-
1999
- 1999-09-17 IS IS5186A patent/IS5186A/en unknown
- 1999-09-24 NO NO994679A patent/NO994679L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ337793A (en) | 2001-02-23 |
| TR199902315T2 (en) | 2000-05-22 |
| CA2284710A1 (en) | 1998-10-01 |
| NO994679D0 (en) | 1999-09-24 |
| AP9901659A0 (en) | 1999-09-30 |
| EA199900755A1 (en) | 2000-08-28 |
| KR20010005567A (en) | 2001-01-15 |
| CN1257482A (en) | 2000-06-21 |
| AU731394B2 (en) | 2001-03-29 |
| YU47699A (en) | 2001-12-26 |
| IS5186A (en) | 1999-09-17 |
| HUP0001661A3 (en) | 2001-12-28 |
| AU7209498A (en) | 1998-10-20 |
| JP2001518901A (en) | 2001-10-16 |
| PL335865A1 (en) | 2000-05-22 |
| WO1998042673A1 (en) | 1998-10-01 |
| HUP0001661A2 (en) | 2000-09-28 |
| NO994679L (en) | 1999-11-24 |
| BR9808424A (en) | 2000-05-23 |
| EP0971896A1 (en) | 2000-01-19 |
| IL131919A0 (en) | 2001-03-19 |
| GB9706294D0 (en) | 1997-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID26099A (en) | AMIDA DEGREE AND NOSICEPTIN ANTAGONISTS | |
| HK1030768A1 (en) | Cyclic amino acids and derivatives thereof useful as pharmaceutical agents. | |
| ID22889A (en) | ETHYLENA COOPOLYMER COMPOSITION AND ITS USE | |
| ID19586A (en) | SILICA-SODA-LIME GRASS COMPOSITION AND ITS USE | |
| ID21361A (en) | BATTERY AND THE MANUFACTURE METHOD | |
| ID25591A (en) | META-AZASICLIC AMINO BENZOAT ACID COMPOUNDS AND ITS DECLARATION ARE INTEGRIN ANTAGONISTS | |
| ID24686A (en) | AMINO ACID BIOSINETIC PLANTS | |
| ID22873A (en) | HETEROSICLIC COMPOUNDS AND ITS USE TO INITIATE B-AMYLOID PEPTIDES | |
| ID19253A (en) | VITRONEKTIN RECEPTOR ANTAGONISTS, ITS MANUFACTURE AND USE OF IT | |
| ID24196A (en) | COMPOSITION AND USE | |
| ID22916A (en) | ERGOLIN DECREASES AND ITS USE AS SOMATOSTATIN RECEPTOR ANTAGONISTS | |
| NO993901D0 (en) | Bicyclic amino acids | |
| ID19245A (en) | VITRONEKTIN RECEPTOR ANTAGONISTS, THE PRODUCTION AND USE OF IT | |
| HUP0003484A3 (en) | Pyrrolidine-3-crboxylic acid derivatives and their use as endothelin antagonists | |
| EE200000226A (en) | 3,6-Half-Ketals of the 9a-Azalides, Method of Preparation and Pharmaceutical Composition | |
| PT878467E (en) | 6-AMINOTETRAHYDROISOQUINOLINACARBOXYLIC ACID AND SUBSTITUTED 7-AMINOTETHYDROISOQUINOLINACARBOXYLS | |
| ID24306A (en) | KUINOLIN-2 CARCOXICATE ACID DECREASE AND ITS USE AS AMITO EXITATORY AMINO ANTAGONISTS | |
| DE69513832D1 (en) | EXCITATIVE AMINO ACID RECEPTOR ANTAGONISTS | |
| ID24810A (en) | SUBSTITUTED ISOQUINOLIN DECREASES AND ITS USE AS ANTI-SEIZURE | |
| ID26234A (en) | HETEROSICLIC CARBOXICATE ACID DECREASES, PRODUCTION AND USE AS ENDOTELEN RECEPTOR ANTAGONISTS | |
| PT964867E (en) | ANTAGONISTS OF THE TAQUICINIMA | |
| DE69801856D1 (en) | Fastener | |
| ID25857A (en) | PHARMACEUTICAL COMPOSITION | |
| ID24346A (en) | OF BETHA-AMINO AND BETHA -AZIDO ACID CARBOXICATE ACID, MAKING AND USING IT AS ANDOTELIN RECEPTOR ANTAGONISTS | |
| ID27133A (en) | SULFONYLAMINOFINE ACID AND PHOSPHONEATE ACID DERIVATES |